GSK plc.

In News

Key facts: GSK Buys Back Shares; FDA Approves RSV Vaccines; Deal Renewed - TradingView

TradingView - Feb 24, 2026

$250M drug manufacturing pact backs uninterrupted HIV and malaria meds - Stock Titan

Stock Titan - Feb 23, 2026

GSK plc (GSK) Stock Analysis: Navigating Opportunities in the Healthcare Giant with a Robust 43.31% ROE - DirectorsTalk Interviews

DirectorsTalk Interviews - Feb 23, 2026

GSK's Rockville R&D campus preps for major renovation to attract new tenants - The Business Journals

The Business Journals - Jan 21, 2026

GSK Is Eyeing $55 Billion In Sales — And It Has Nothing To Do With Obesity - Investor's Business Daily

Investor's Business Daily - Feb 04, 2026

GSK plc (GSK) Q4 Results Topped Forecasts as Specialty Medicines Jump 17% - Yahoo Finance

Yahoo Finance - Feb 15, 2026

GSK delivers strong 2025 performance and re-affirms long-term outlooks - GSK

GSK - Feb 04, 2026

GSK plc (LON:GSK) Is About To Go Ex-Dividend, And It Pays A 3.3% Yield - Yahoo Finance

Yahoo Finance - Feb 13, 2026

GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding - GSK

GSK - Jan 20, 2026

GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) (NYSE:GSK) - Seeking Alpha

Seeking Alpha - Feb 17, 2026

GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years - GSK

GSK - Sep 17, 2025

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology - GSK

GSK - Jul 28, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment